The global market for Mantle Cell Lymphoma Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Mantle Cell Lymphoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mantle Cell Lymphoma Treatment.

The Mantle Cell Lymphoma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mantle Cell Lymphoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mantle Cell Lymphoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Mantle Cell Lymphoma Treatment Market Report

Report Metric	Details
Report Name	Mantle Cell Lymphoma Treatment Market
CAGR	5%
Segment by Type	Acalabrutinib JCAR-017 JNJ-64052781 Acalisib IGN-002 IMGN-529 AFM-11 Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astex Pharmaceuticals, Inc., Bayer AG, Bristol-Myers Squibb Company, Celgene Corporation, Cellular Biomedicine Group, Inc., Eisai, EpiZyme, Inc., Fate Therapeutics, Inc., Genentech, Inc., Gilead Sciences, Inc., GlaxoSmithKline Plc, Hutchison MediPharma Limited, ImmunoGen, Inc., Immunomedics, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mantle Cell Lymphoma Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Mantle Cell Lymphoma Treatment Market report?

Ans: The main players in the Mantle Cell Lymphoma Treatment Market are Astex Pharmaceuticals, Inc., Bayer AG, Bristol-Myers Squibb Company, Celgene Corporation, Cellular Biomedicine Group, Inc., Eisai, EpiZyme, Inc., Fate Therapeutics, Inc., Genentech, Inc., Gilead Sciences, Inc., GlaxoSmithKline Plc, Hutchison MediPharma Limited, ImmunoGen, Inc., Immunomedics, Inc.

What are the Application segmentation covered in the Mantle Cell Lymphoma Treatment Market report?

Ans: The Applications covered in the Mantle Cell Lymphoma Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Mantle Cell Lymphoma Treatment Market report?

Ans: The Types covered in the Mantle Cell Lymphoma Treatment Market report are Acalabrutinib, JCAR-017, JNJ-64052781, Acalisib, IGN-002, IMGN-529, AFM-11, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Acalabrutinib

1.2.3 JCAR-017

1.2.4 JNJ-64052781

1.2.5 Acalisib

1.2.6 IGN-002

1.2.7 IMGN-529

1.2.8 AFM-11

1.2.9 Others

1.3 Market by Application

1.3.1 Global Mantle Cell Lymphoma Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Mantle Cell Lymphoma Treatment Market Perspective (2020-2031)

2.2 Global Mantle Cell Lymphoma Treatment Growth Trends by Region

2.2.1 Global Mantle Cell Lymphoma Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Mantle Cell Lymphoma Treatment Historic Market Size by Region (2020-2025)

2.2.3 Mantle Cell Lymphoma Treatment Forecasted Market Size by Region (2026-2031)

2.3 Mantle Cell Lymphoma Treatment Market Dynamics

2.3.1 Mantle Cell Lymphoma Treatment Industry Trends

2.3.2 Mantle Cell Lymphoma Treatment Market Drivers

2.3.3 Mantle Cell Lymphoma Treatment Market Challenges

2.3.4 Mantle Cell Lymphoma Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue

3.1.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue (2020-2025)

3.1.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Mantle Cell Lymphoma Treatment Revenue

3.4 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio

3.4.1 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Mantle Cell Lymphoma Treatment Revenue in 2024

3.5 Global Key Players of Mantle Cell Lymphoma Treatment Head office and Area Served

3.6 Global Key Players of Mantle Cell Lymphoma Treatment, Product and Application

3.7 Global Key Players of Mantle Cell Lymphoma Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Mantle Cell Lymphoma Treatment Breakdown Data by Type

4.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Type (2020-2025)

4.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2026-2031)

5 Mantle Cell Lymphoma Treatment Breakdown Data by Application

5.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Application (2020-2025)

5.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Mantle Cell Lymphoma Treatment Market Size (2020-2031)

6.2 North America Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)

6.4 North America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Mantle Cell Lymphoma Treatment Market Size (2020-2031)

7.2 Europe Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)

7.4 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size (2020-2031)

8.2 Asia-Pacific Mantle Cell Lymphoma Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Mantle Cell Lymphoma Treatment Market Size (2020-2031)

9.2 Latin America Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)

9.4 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size (2020-2031)

10.2 Middle East & Africa Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Astex Pharmaceuticals, Inc.

11.1.1 Astex Pharmaceuticals, Inc. Company Details

11.1.2 Astex Pharmaceuticals, Inc. Business Overview

11.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Introduction

11.1.4 Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.1.5 Astex Pharmaceuticals, Inc. Recent Development

11.2 Bayer AG

11.2.1 Bayer AG Company Details

11.2.2 Bayer AG Business Overview

11.2.3 Bayer AG Mantle Cell Lymphoma Treatment Introduction

11.2.4 Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.2.5 Bayer AG Recent Development

11.3 Bristol-Myers Squibb Company

11.3.1 Bristol-Myers Squibb Company Company Details

11.3.2 Bristol-Myers Squibb Company Business Overview

11.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Introduction

11.3.4 Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.3.5 Bristol-Myers Squibb Company Recent Development

11.4 Celgene Corporation

11.4.1 Celgene Corporation Company Details

11.4.2 Celgene Corporation Business Overview

11.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Introduction

11.4.4 Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.4.5 Celgene Corporation Recent Development

11.5 Cellular Biomedicine Group, Inc.

11.5.1 Cellular Biomedicine Group, Inc. Company Details

11.5.2 Cellular Biomedicine Group, Inc. Business Overview

11.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Introduction

11.5.4 Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.5.5 Cellular Biomedicine Group, Inc. Recent Development

11.6 Eisai

11.6.1 Eisai Company Details

11.6.2 Eisai Business Overview

11.6.3 Eisai Mantle Cell Lymphoma Treatment Introduction

11.6.4 Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.6.5 Eisai Recent Development

11.7 EpiZyme, Inc.

11.7.1 EpiZyme, Inc. Company Details

11.7.2 EpiZyme, Inc. Business Overview

11.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Introduction

11.7.4 EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.7.5 EpiZyme, Inc. Recent Development

11.8 Fate Therapeutics, Inc.

11.8.1 Fate Therapeutics, Inc. Company Details

11.8.2 Fate Therapeutics, Inc. Business Overview

11.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Introduction

11.8.4 Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.8.5 Fate Therapeutics, Inc. Recent Development

11.9 Genentech, Inc.

11.9.1 Genentech, Inc. Company Details

11.9.2 Genentech, Inc. Business Overview

11.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Introduction

11.9.4 Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.9.5 Genentech, Inc. Recent Development

11.10 Gilead Sciences, Inc.

11.10.1 Gilead Sciences, Inc. Company Details

11.10.2 Gilead Sciences, Inc. Business Overview

11.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Introduction

11.10.4 Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.10.5 Gilead Sciences, Inc. Recent Development

11.11 GlaxoSmithKline Plc

11.11.1 GlaxoSmithKline Plc Company Details

11.11.2 GlaxoSmithKline Plc Business Overview

11.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Introduction

11.11.4 GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.11.5 GlaxoSmithKline Plc Recent Development

11.12 Hutchison MediPharma Limited

11.12.1 Hutchison MediPharma Limited Company Details

11.12.2 Hutchison MediPharma Limited Business Overview

11.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Introduction

11.12.4 Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.12.5 Hutchison MediPharma Limited Recent Development

11.13 ImmunoGen, Inc.

11.13.1 ImmunoGen, Inc. Company Details

11.13.2 ImmunoGen, Inc. Business Overview

11.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Introduction

11.13.4 ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.13.5 ImmunoGen, Inc. Recent Development

11.14 Immunomedics, Inc.

11.14.1 Immunomedics, Inc. Company Details

11.14.2 Immunomedics, Inc. Business Overview

11.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Introduction

11.14.4 Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)

11.14.5 Immunomedics, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astex Pharmaceuticals Inc

Bayer

Bristol Myers Squibb Company

Celgene Corporation

Cellular Biomedicine Group Inc

Eisai Co Ltd

EpiZyme Inc

Fate Therapeutics, Inc

Genentech Inc

Gilead Sciences Inc

GlaxoSmithKline PLC

Hutchison MediPharma Limited

ImmunoGen Inc

Immunomedics

List of Tables

Table 1. Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Acalabrutinib

Table 3. Key Players of JCAR-017

Table 4. Key Players of JNJ-64052781

Table 5. Key Players of Acalisib

Table 6. Key Players of IGN-002

Table 7. Key Players of IMGN-529

Table 8. Key Players of AFM-11

Table 9. Global Mantle Cell Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Mantle Cell Lymphoma Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Mantle Cell Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Mantle Cell Lymphoma Treatment Market Share by Region (2020-2025)

Table 13. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Mantle Cell Lymphoma Treatment Market Share by Region (2026-2031)

Table 15. Mantle Cell Lymphoma Treatment Market Trends

Table 16. Mantle Cell Lymphoma Treatment Market Drivers

Table 17. Mantle Cell Lymphoma Treatment Market Challenges

Table 18. Mantle Cell Lymphoma Treatment Market Restraints

Table 19. Global Mantle Cell Lymphoma Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Mantle Cell Lymphoma Treatment Market Share by Players (2020-2025)

Table 21. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2024)

Table 22. Ranking of Global Top Mantle Cell Lymphoma Treatment Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Mantle Cell Lymphoma Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Mantle Cell Lymphoma Treatment, Headquarters and Area Served

Table 25. Global Key Players of Mantle Cell Lymphoma Treatment, Product and Application

Table 26. Global Key Players of Mantle Cell Lymphoma Treatment, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Mantle Cell Lymphoma Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2020-2025)

Table 30. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2026-2031)

Table 32. Global Mantle Cell Lymphoma Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Application (2020-2025)

Table 34. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Application (2026-2031)

Table 36. North America Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 51. Astex Pharmaceuticals, Inc. Company Details

Table 52. Astex Pharmaceuticals, Inc. Business Overview

Table 53. Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Product

Table 54. Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 55. Astex Pharmaceuticals, Inc. Recent Development

Table 56. Bayer AG Company Details

Table 57. Bayer AG Business Overview

Table 58. Bayer AG Mantle Cell Lymphoma Treatment Product

Table 59. Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 60. Bayer AG Recent Development

Table 61. Bristol-Myers Squibb Company Company Details

Table 62. Bristol-Myers Squibb Company Business Overview

Table 63. Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Product

Table 64. Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 65. Bristol-Myers Squibb Company Recent Development

Table 66. Celgene Corporation Company Details

Table 67. Celgene Corporation Business Overview

Table 68. Celgene Corporation Mantle Cell Lymphoma Treatment Product

Table 69. Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 70. Celgene Corporation Recent Development

Table 71. Cellular Biomedicine Group, Inc. Company Details

Table 72. Cellular Biomedicine Group, Inc. Business Overview

Table 73. Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Product

Table 74. Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 75. Cellular Biomedicine Group, Inc. Recent Development

Table 76. Eisai Company Details

Table 77. Eisai Business Overview

Table 78. Eisai Mantle Cell Lymphoma Treatment Product

Table 79. Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 80. Eisai Recent Development

Table 81. EpiZyme, Inc. Company Details

Table 82. EpiZyme, Inc. Business Overview

Table 83. EpiZyme, Inc. Mantle Cell Lymphoma Treatment Product

Table 84. EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 85. EpiZyme, Inc. Recent Development

Table 86. Fate Therapeutics, Inc. Company Details

Table 87. Fate Therapeutics, Inc. Business Overview

Table 88. Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Product

Table 89. Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 90. Fate Therapeutics, Inc. Recent Development

Table 91. Genentech, Inc. Company Details

Table 92. Genentech, Inc. Business Overview

Table 93. Genentech, Inc. Mantle Cell Lymphoma Treatment Product

Table 94. Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 95. Genentech, Inc. Recent Development

Table 96. Gilead Sciences, Inc. Company Details

Table 97. Gilead Sciences, Inc. Business Overview

Table 98. Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Product

Table 99. Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 100. Gilead Sciences, Inc. Recent Development

Table 101. GlaxoSmithKline Plc Company Details

Table 102. GlaxoSmithKline Plc Business Overview

Table 103. GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Product

Table 104. GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 105. GlaxoSmithKline Plc Recent Development

Table 106. Hutchison MediPharma Limited Company Details

Table 107. Hutchison MediPharma Limited Business Overview

Table 108. Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Product

Table 109. Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 110. Hutchison MediPharma Limited Recent Development

Table 111. ImmunoGen, Inc. Company Details

Table 112. ImmunoGen, Inc. Business Overview

Table 113. ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Product

Table 114. ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 115. ImmunoGen, Inc. Recent Development

Table 116. Immunomedics, Inc. Company Details

Table 117. Immunomedics, Inc. Business Overview

Table 118. Immunomedics, Inc. Mantle Cell Lymphoma Treatment Product

Table 119. Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)

Table 120. Immunomedics, Inc. Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Mantle Cell Lymphoma Treatment Picture

Figure 2. Global Mantle Cell Lymphoma Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Mantle Cell Lymphoma Treatment Market Share by Type: 2024 VS 2031

Figure 4. Acalabrutinib Features

Figure 5. JCAR-017 Features

Figure 6. JNJ-64052781 Features

Figure 7. Acalisib Features

Figure 8. IGN-002 Features

Figure 9. IMGN-529 Features

Figure 10. AFM-11 Features

Figure 11. Others Features

Figure 12. Global Mantle Cell Lymphoma Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Mantle Cell Lymphoma Treatment Market Share by Application: 2024 VS 2031

Figure 14. Hospital Case Studies

Figure 15. Clinic Case Studies

Figure 16. Others Case Studies

Figure 17. Mantle Cell Lymphoma Treatment Report Years Considered

Figure 18. Global Mantle Cell Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Mantle Cell Lymphoma Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Mantle Cell Lymphoma Treatment Market Share by Region: 2024 VS 2031

Figure 21. Global Mantle Cell Lymphoma Treatment Market Share by Players in 2024

Figure 22. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Mantle Cell Lymphoma Treatment Revenue in 2024

Figure 24. North America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)

Figure 26. United States Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)

Figure 30. Germany Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Mantle Cell Lymphoma Treatment Market Share by Region (2020-2031)

Figure 38. China Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)

Figure 46. Mexico Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)

Figure 50. Turkey Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Astex Pharmaceuticals, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 54. Bayer AG Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 56. Celgene Corporation Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 57. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 58. Eisai Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 59. EpiZyme, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 60. Fate Therapeutics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 61. Genentech, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 62. Gilead Sciences, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 63. GlaxoSmithKline Plc Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 64. Hutchison MediPharma Limited Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 65. ImmunoGen, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 66. Immunomedics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Precision Cancer Imaging System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z10214

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Cryosurgical Equipment for Cancer Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39B12765

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Brachytherapy Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24Q18678

Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Gynecological Cancer Diagnostics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30P10282

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions